U.S Class(es): 006, 018, 044, 046, 051, 052
| Name | Novartis Pharma AG, Trademark Department |
|---|---|
| Address | Postfach CH-4002 Basel, SWITZERLAND |
| Date | Description | Action Tags | Code |
|---|---|---|---|
| Aug-04-2016 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | SDRCM | |
| Aug-05-2016 | LIMITATION FROM ORIGINAL APPLICATION ENTERED | LIMII | |
| Aug-08-2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
| Aug-09-2016 | ASSIGNED TO EXAMINER | DOCKD | |
| Aug-12-2016 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
| Aug-15-2016 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
| Sep-07-2016 | NOTICE OF PUBLICATION | NPUBO | |
| Sep-07-2016 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | OP2RP | |
| Sep-07-2016 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | OPNSP | |
| Sep-27-2016 | PUBLISHED FOR OPPOSITION | PUBOA | |
| Dec-13-2016 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
| Jan-12-2017 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
| Feb-15-2017 | FINAL DISPOSITION PROCESSED | FIMPP | |
| Feb-15-2017 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
| Jun-30-2017 | NOTIFICATION PROCESSED BY IB | GPNXP | |
| Oct-27-2017 | NOTIFICATION PROCESSED BY IB | GPNXP | |
| Jun-30-2023 | CANCELLED SECTION 71 | C71TO | |
| Feb-29-2024 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | INTRP | |
| Apr-11-2025 | GENERIC MADRID TRANSACTION CREATED | XXCRP | |
| Apr-11-2025 | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | INNAR | |
| Apr-11-2025 | GENERIC MADRID TRANSACTION SENT TO IB | XXSSO | |
| May-31-2025 | Further Decision Processed by IB |